October 15, 2024

Concomitant Corticosteroid Use Decreased in Myasthenia Gravis Through Ravulizumab – Neurology Live

October 14, 2024

Efgartigimod treatment for generalized myasthenia gravis: a single-center case series of 16 patients – Frontiers

September 25, 2024

With success in myasthenia gravis trial, Amgen’s Uplizna looks set up to add new indication – FiercePharma

September 25, 2024

Amgen Scores Late-Stage Wins in Eczema and Myasthenia Gravis, But Analysts See Mixed Results – BioSpace

September 24, 2024

Amgen scores late-stage trial success for eczema and myasthenia gravis treatments, but faces stiff competition – STAT